Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA greenlights Musk's Neuralink trials

Musk has made many radical claims regarding his future vision for the technology. What comes after FDA approval?

Salon

How To Restrain the A.I. Regulators

A more flexible model of oversight avoids hyper-cautious top-down regulation and enables swifter access to the substantial benefits of safe A.I.

Reason

Manus Neurodynamica scoops £2.6m to support marketing of its brain disorder tech

The firm has developed a tool that can help faster and simpler diagnosis of diseases such as Parkinson's

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

'Artificial pancreas' lowers disease management burden for diabetic people: Study

Type 1 diabetes affects 46.3 million individuals globally, with an annual rise of roughly 3 per cent. Read further on Dynamite News:

Dynamite News

3 Value Stocks With Great Returns

April’s robust labor market and persistently high inflation could strengthen the likelihood of interest rates remaining elevated for an extended period. So, fundamentally strong value stocks CIRCOR International (CIR), Consolidated Water (CWCO), and Cidara Therapeutics (CDTX), which have generated solid returns, could be one’s top picks now. Keep reading.

StockNews.com

Consumer watchdog says KOS protein powder contains toxic PFAS

The Environmental Research Center says it tested five products and found toxic ‘forever chemicals’ linked to serious disease

The Guardian - US

The FDA finally approved Elon Musk's Neuralink chip for human trials. Have all the concerns been addressed?

Since its founding in 2016, Elon Musk’s neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved by the US Food and Drug Administration (FDA).

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Key facts about Neuralink, Musk's cyborg gamble

Key facts about Neuralink, Elon musk’s neurotechnology company. It aims to supercharge human capabilities, treat neurological disorders like ALS or Parkinson’s

The Hindu

Sister of UK's first flesh-eating zombie drug victim issues warning over 'evil killer'

Karl Warburton has become the first person to die of xylazine in the UK - and his sister Diane has spoken about her fears that the killer drug could cause even more deaths around the UK

Daily Mirror

Elon Musk gets the OK for brain implants, and everyone's making the same joke

Neuralink gets the green light to test its brain-computer interface with human subjects

Creating a sperm or egg from any cell? Reproduction revolution on the horizon

Researchers are inching closer to creating human eggs and sperm in the lab that carry a full complement of anyone's DNA. It could revolutionize fertility treatment and raises huge ethical questions.

WEKU

Elon Musk’s Brain Chip Company Gets FDA Greenlight For ‘First-In-Human Clinical Study’

Neuralink gets FDA approval for human trial, a major stride in Musk's brain-implant tech vision.

Zenger

Elon Musk battles regulators and animal-cruelty allegations to launch brain-implant trials

Elon Musk's Neuralink can start its first human clinical trial of brain implants, as it faces probes over animal experiments.

The New Daily

Key facts about Neuralink, Musk's cyborg gamble

WASHINGTON - Neuralink, Elon Musk's brain-implant company, has won US approval to test on humans. Here is what to know about the multi-billionaire's dream project to enable the human brain to communicate directly with computers.

Bangkok Post

Get all your
news in one place.

100’s of premium titles.
One news app.

PC Gamer

Oh good: Elon Musk's Neuralink gets FDA approval to put microchips in human brains

This is fine!

Fortune

This is your brain on Elon Musk

The multi-tasking, helter-skelter billionaire wants to put chips in our brains with his Neuralink company, and the FDA just gave him the go-ahead.

The Guardian - UK

Civil service unions enter new pay talks with UK government

Prospect and FDA suspend strike action after offer of ‘meaningful’ talks, with PCS also attending

Axios

Musk's Neuralink says it won FDA approval for human trials

Elon Musk's Neuralink said it has been cleared by the FDA to begin human trials on its brain-implant technology.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Elon Musk says his Neuralink brain chips have been approved for trials on humans

Patients have been able to register their interest to enroll in tests since earlier in the year

Daily Mirror

Elon Musk's 'mind control chip' is cleared for human testing despite monkey deaths

Human trials will start soon on a brain implant which aims to help treat people with autism, obesity and a range of other conditions, despite earlier rejections over animal deaths

Bangkok Post

B4 million in fake herbal products seized

Police have confiscated fake herbal products worth about 4 million baht during raids on four locations in Bangkok and Pathum Thani following an investigation into sales of the products by Chinese nationals to Chinese tourists.

The Independent UK

Elon Musk’s Neuralink brain chip company says it now has FDA approval for human testing

Brain chip firm has reportedly killed about 1,500 animals, including over 280 sheep, pigs and, monkeys

Fortune

Elon Musk's futuristic brain chip startup Neuralink gets FDA approval for human testing that 'represents an important first step'

Musk has pitched his startup and its technology, which requires drilling into patients' skulls, as potentially helping people with paralysis.

Fortune

Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars

While rare diseases impact a small population, the cost to society is staggering. It may be in the range of $7.2-$8.6 trillion per year.

Salon

A psychedelic clue to the cause of SIDS

A new study using radioactive psychedelics suggests that infants who die of SIDS have abnormal serotonin receptors

1 … 111 112 113 114

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.